ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,352Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 609

$1.16M Total Retail Price of All Prescriptions

Rank: 12 out of 609

727 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 727 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

2% of this provider’s 727 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 18,324 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 36%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $117 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 909 885 1 2
SIMVASTATIN 802 786 2 1
METOPROLOL TARTRATE 698 679 3 9
FUROSEMIDE 639 605 4 4
METFORMIN HCL 544 520 5 10
DONEPEZIL HCL 390 388 6 22
ENALAPRIL MALEATE 389 376 7 32
CLOPIDOGREL 386 386 8 17
HYDROCHLOROTHIAZIDE 356 353 9 20
OMEPRAZOLE 313 287 10 3
FAMOTIDINE 294 263 11 50
ATORVASTATIN CALCIUM 283 280 12 6
TRAMADOL HCL 282 278 13 39
LACTULOSE 272 263 14 109
PLAVIX 271 271 15 25
ZOLPIDEM TARTRATE 252 228 16 18
LISINOPRIL 246 236 17 12
MIRTAZAPINE 240 237 18 58
OXYCODONE-ACETAMINOPHEN 232 206 S2 19 44
LIDODERM 231 231 20 81
METOPROLOL SUCCINATE 230 227 21 5
RISPERIDONE 229 226 22 107
DIOVAN 218 215 23 15
POTASSIUM CHLORIDE 215 209 24 40
CARVEDILOL 204 194 25 14
LEVOTHYROXINE SODIUM 199 184 26 7
GABAPENTIN 183 170 27 21
WARFARIN SODIUM 179 115 28 8
POLYETHYLENE GLYCOL 3350 178 171 29 99
NAMENDA 178 172 29 36
SANTYL 176 168 31 186
CRESTOR 169 161 32 16
FLUTICASONE PROPIONATE 166 163 33 52
PANTOPRAZOLE SODIUM 165 161 34 29
LANTUS 158 151 35 82
NEXIUM 155 149 36 13
HYDRALAZINE HCL 155 152 36 133
ISOSORBIDE MONONITRATE ER 135 134 38 62
DIOVAN HCT 133 133 39 31
AMLODIPINE BESYLATE-BENAZEPRIL 130 118 40 88
GLIMEPIRIDE 127 125 41 53
DIGOXIN 124 121 42 33
LEVETIRACETAM 116 85 43 70
ATENOLOL 114 114 44 27
PROAIR HFA 113 96 45 57
LANTUS SOLOSTAR 110 95 46 63
SINGULAIR 109 107 47 78
JANUVIA 108 108 48 34
TAMSULOSIN HCL 102 93 49 11
ESCITALOPRAM OXALATE 100 99 50 91
NOVOLOG 98 89 51 156
PHENYTOIN SODIUM EXTENDED 95 89 52 206
LOSARTAN POTASSIUM 93 92 53 24
ALLOPURINOL 90 79 54 75
ENOXAPARIN SODIUM 89 41 55 264
ADVAIR DISKUS 88 79 56 28
GLIPIZIDE 88 88 56 169
COLCRYS 88 86 56 245
LIPITOR 87 87 59 47
NIFEDIPINE ER 85 80 60 230
PREDNISONE 84 75 61 26
CYMBALTA 82 78 62 76
CLONIDINE HCL 81 66 63 83
MONTELUKAST SODIUM 77 70 64 152
AMIODARONE HCL 76 65 65 158
NOVOLOG FLEXPEN 75 63 66 122
SPIRONOLACTONE 72 69 67 105
RAMIPRIL 67 67 68 46
IBUPROFEN 66 62 69 103
FENTANYL 63 63 S2 70 66
SILVER SULFADIAZINE 62 52 71 375
ALENDRONATE SODIUM 60 60 72 54
LEVOFLOXACIN 60 55 72 127
RANITIDINE HCL 57 57 74 141
EXELON 57 57 74 142
TRAZODONE HCL 55 52 76 113
CARBIDOPA-LEVODOPA 55 55 76 49
LYRICA 54 54 78 90
GLYBURIDE 53 53 R 79 132
ALBUTEROL SULFATE 53 35 79 201
BYSTOLIC 52 52 81 71
LATANOPROST 51 51 82 19
IPRATROPIUM-ALBUTEROL 51 49 82 173
SPIRIVA 50 46 84 43
AZITHROMYCIN 50 47 84 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.